Abstract:Dermatophytes are a group of pathogenic fungi that exclusively infect the stratum corneum of the skin, nails, and hair, causing dermatophytosis. Superficial skin infections caused by dermatophytes have increased in the last decades. There are conventional antifungals that treat these infections, such as terbinafine, fluconazole, and others. However, the limitations of these treatments (resistance, side effects and toxicity) along with the increasing over-prescription, the misuse of these antifungals and the hi… Show more
“…Conventional antifungal drugs used in dermatophytosis such as terbinafine present difficulties, and resistance of dermatophytes has been increasingly reported, which leads to the search for new natural, alternative antifungals (Lopes et al 2019). In this context, the antifungal activity of monoterpenes against pathogenic dermatophytes was evaluated in this study.…”
Significance and Impact of the Study: This is the first study that describes the dihydrojasmone and terpinolene action enhancing the antifungal activity of terbinafine against dermatophytes. In vitro tests have demonstrated that the monoterpenes act on the plasma membrane, positively modulating the sensitivity of fungal strains to terbinafine by a synergism association. We suggest that monoterpenes can be an effective and sustainable alternative while contributing to the reduction of the dermatophytes resistance to conventional drugs.
“…Conventional antifungal drugs used in dermatophytosis such as terbinafine present difficulties, and resistance of dermatophytes has been increasingly reported, which leads to the search for new natural, alternative antifungals (Lopes et al 2019). In this context, the antifungal activity of monoterpenes against pathogenic dermatophytes was evaluated in this study.…”
Significance and Impact of the Study: This is the first study that describes the dihydrojasmone and terpinolene action enhancing the antifungal activity of terbinafine against dermatophytes. In vitro tests have demonstrated that the monoterpenes act on the plasma membrane, positively modulating the sensitivity of fungal strains to terbinafine by a synergism association. We suggest that monoterpenes can be an effective and sustainable alternative while contributing to the reduction of the dermatophytes resistance to conventional drugs.
“…It is known that such compounds are lipophilic and have a small molecular size which enable their passive diffusion through fungi membranes [16]. Volatile compounds exert their fungicidal activity through different mechanisms of action that include, among others, the perturbation of the lipid membrane organization [60] followed by the increased permeability of the fungal cell wall/membrane, the extravasation of cell constituents, the inhibition of ergosterol synthesis, and cell lysis [15,23]. Moreover, it was reported that several main constituents of the Apiaceae EOs included in our study acted on the virulence factors and resistance mechanisms of T. rubrum.…”
Section: Discussionmentioning
confidence: 99%
“…Distillation or pressing are physical processes used to obtain EOs, which comprise a blend of small volatile molecules that act as signaling agents in plants (e.g., attraction of pollinators, antifeedant agents, and protection against microorganisms) [21,22]. The antidermatophytic propensities of EOs are also well-documented and include the disruption of the cell wall/membrane; the inhibition of spore germination, ergosterol and cellular proteins synthesis; efflux pumps, and biofilm formation [23,24]. Moreover, EOs exhibit anti-inflammatory effects, thus supporting lesion healing and alleviating symptoms related to dermatophytosis [14,15].…”
Dermatophyte infections represent an important public health concern, affecting up to 25% of the world’s population. Trichophyton rubrum and T. mentagrophytes are the predominant dermatophytes in cutaneous infections, with a prevalence accounting for 70% of dermatophytoses. Although terbinafine represents the preferred treatment, its clinical use is hampered by side effects, drug–drug interactions, and the emergence of resistant clinical isolates. Combination therapy, associating terbinafine and essential oils (EOs), represents a promising strategy in the treatment of dermatophytosis. In this study, we screened the potential of selected Apiaceae EOs (ajowan, coriander, caraway, and anise) to improve the antifungal activity of terbinafine against T. rubrum ATCC 28188 and T. mentagrophytes ATCC 9533. The chemical profile of EOs was analyzed by gas chromatography. The minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of EOs/main compounds were determined according to EUCAST-AFST guidelines, with minor modifications. The checkerboard microtiter method was used to identify putative synergistic combinations of EOs/main constituents with terbinafine. The influence of EOs on the viability and pro-inflammatory cytokine production (IL-1β, IL-8 and TNF-α) was determined using an ex vivo human neutrophils model. The binary associations of tested EOs with terbinafine were found to be synergistic against T. rubrum, with FICI values of 0.26–0.31. At the tested concentrations (6.25–25 mg/L), EOs did not exert cytotoxic effects towards human neutrophils. Anise EO was the most potent inhibitor of IL-1β release (46.49% inhibition at 25 mg/L), while coriander EO displayed the highest inhibition towards IL-8 and TNF-α production (54.15% and 54.91%, respectively). In conclusion, the synergistic combinations of terbinafine and investigated Apiaceae EOs could be a starting point in the development of novel topical therapies against T. rubrum-related dermatophytosis.
“…Triazoles inhibit sterol 14-α-demethylase, and allylamines inhibit squalene epoxidase, the inhibition of both enzymes leading to inhibition of ergosterol biosynthesis. Allylamines also lead to the accumulation of lanosterol, a toxic intermediary compound of the ergosterol biosynthesis pathway [8][9][10]. Terbinafine, which acts as a fungicide, is the drug of choice against Trichophyton spp.…”
Dermatophytes are the most common cause of fungal infections worldwide, affecting millions of people annually. The emergence of resistance among dermatophytes along with the availability of antifungal susceptibility procedures suitable for testing antifungal agents against this group of fungi make the combinatorial approach particularly interesting to be investigated. Therefore, we reviewed the scientific literature concerning the antifungal combinations against dermatophytes. A literature search on the subject performed in PubMed yielded 68 publications: 37 articles referring to in vitro studies and 31 articles referring to case reports or clinical studies. In vitro studies involved over 400 clinical isolates of dermatophytes (69% Trichophyton spp., 29% Microsporum spp., and 2% Epidermophyton floccosum). Combinations included two antifungal agents or an antifungal agent plus another chemical compound including plant extracts or essential oils, calcineurin inhibitors, peptides, disinfectant agents, and others. In general, drug combinations yielded variable results spanning from synergism to indifference. Antagonism was rarely seen. In over 700 patients with documented dermatophyte infections, an antifungal combination approach could be evaluated. The most frequent combination included a systemic antifungal agent administered orally (i.e., terbinafine, griseofulvin, or azole—mainly itraconazole) plus a topical medication (i.e., azole, terbinafine, ciclopirox, amorolfine) for several weeks. Clinical results indicate that association of antifungal agents is effective, and it might be useful to accelerate the clinical and microbiological healing of a superficial infection. Antifungal combinations in dermatophytes have gained considerable scientific interest over the years and, in consideration of the interesting results available so far, it is desirable to continue the research in this field.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.